Ciprofloxacin analogs with various substitutions on the piperazine nitrogen were tested aginst several mycobacteria. In contrast to what has been found with other gram-positive and gram-negative bacteria, alkyl analogs such as N-isopropylclproloxacin were shown to be snicandy more active than ciprofloxacin. MICs of 0.125 ,g/ml against Mycobacterium tuberculosis were found.
The fluoroquinolones show pronounced activity against mycobacteria. Among the most interesting compounds in clinical use currently are ciprofloxacin and ofloxacin. They are possible candidates to be used in the treatment of mycobacteriosis (6) .
Most fluoroquinolones possess a nitrogen-containing cyclic substituent on the quinolone nucleus. Although several ring structures are possible, the 1-piperazinyl substituent and the 4-methyl-1-piperazinyl substituent are the most common ones. Higher alkyl chains yield compounds that are less active against gram-positive and gram-negative bacteria (1, 2, 5).
Our aim was to investigate whether both substituents were also the best when tested against mycobacteria. Hence we tested several N-substituted ciprofloxacin analogs against a series of mycobacteria. N-Methyl-and N-ethylciprofloxacin (enrofloxacin) were prepared from ciprofloxacin, respectively, by an Eschweiler-Clark methylation and with an ethyl iodide alkylation as described in the literature (3, 5) (K. Grohe, H.-J. Zeiler, K. Metzger, and H. Heitzer; German patent DE 3142854; Bayer AG, October 1981). N-Isopropyl-, N-propyl-, N-phenyl-, and N-benzylciprofloxacin were kindly provided by Bayer AG, Leverkusen, Federal Republic of Germany.
These compounds were tested against a number of mycobacterial strains from our own collection (4) by the agar dilution method. The inoculum was a 1-,ul suspension of about 104 CFU grown in Dubos broth without Tween. Middlebrook 7H10 agar with 10%o oleic acid-albumin-dextrose solution was used. The incubation time was 5 days to 2 weeks, depending on the growth rate of the strains. Compounds were dissolved in 0.1 N potassium hydroxide solution.
The results are summarized in Tables 1, 2 Against Mycobacterium avium these alkylated ciprofloxacin derivatives were at least twice as active, and against several strains they were even 10 to 20 times more active. Some strains, however, remained unsusceptible. Only a few strains of other mycobacteria were tested. In most cases N alkylation also increased the activity.
N phenylation or N benzylation did not change (M. avium) 
